azimilide has been researched along with Coronary Heart Disease in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 3 (75.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Grönefeld, GC; Hohnloser, SH | 1 |
Connolly, SJ; Kerr, CR; Kowey, P; Page, RL; Pritchett, EL; Ruda, MY; Ruzyllo, W; Wilkinson, WE | 1 |
SoRelle, R | 1 |
1 review(s) available for azimilide and Coronary Heart Disease
Article | Year |
---|---|
[Drug therapy of ventricular arrhythmias - a contemporary perspective].
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Calcium Channel Blockers; Clinical Trials as Topic; Coronary Disease; Death, Sudden, Cardiac; Defibrillators, Implantable; Double-Blind Method; Follow-Up Studies; Heart Failure; Heart Ventricles; Humans; Hydantoins; Imidazoles; Imidazolidines; Meta-Analysis as Topic; Piperazines; Placebos; Primary Prevention; Prospective Studies; Quality of Life; Randomized Controlled Trials as Topic; Risk Factors; Time Factors | 2002 |
1 trial(s) available for azimilide and Coronary Heart Disease
Article | Year |
---|---|
Efficacy of azimilide for the maintenance of sinus rhythm in patients with paroxysmal atrial fibrillation in the presence and absence of structural heart disease.
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Confidence Intervals; Coronary Disease; Electrocardiography; Female; Heart Failure; Heart Rate; Humans; Hydantoins; Imidazolidines; Male; Middle Aged; Piperazines; Tachycardia, Paroxysmal; Treatment Outcome | 2006 |
2 other study(ies) available for azimilide and Coronary Heart Disease
Article | Year |
---|---|
Electrophysiology test may predict SCD (sudden cardiac death) risk: investigators induce VT in CAD patients.
Topics: Anti-Arrhythmia Agents; Coronary Disease; Death, Sudden, Cardiac; Electrophysiology; Humans; Hydantoins; Imidazoles; Imidazolidines; Piperazines; Risk Assessment; Tachycardia, Ventricular; United States | 1999 |
Cardiovascular news.
Topics: Acetanilides; Angina, Unstable; Anti-Arrhythmia Agents; Calcium Channel Blockers; Coronary Disease; Dose-Response Relationship, Drug; Enzyme Inhibitors; Fibrinolytic Agents; Fondaparinux; Humans; Hydantoins; Imidazoles; Imidazolidines; Multicenter Studies as Topic; Myocardial Infarction; Nicorandil; Piperazines; Polysaccharides; Randomized Controlled Trials as Topic; Ranolazine; Treatment Outcome | 2001 |